Clinical Trials Browser

Phase 2 × Appendiceal Neoplasms × surufatinib × Clear all

NCT05472948 2025-12-17

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Phase 2 Recruiting

Gastrointestinal

Appendiceal Neoplasms, Neoplasm Metastasis